Robert E. Waltermire, Senior VP, Chief Pharma Development at MADRIGAL PHARMACEUTICALS, INC. (MDGL), sold 3,800 shares at $216.00 ($847K) on 2023-12-12, disclosed to the SEC on 2023-12-14.
Open-market sale of $847k MDGL by Senior VP, Chief Pharma Development. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $216.00 | 500 | $108K | 12.8% |
| 2 | $219.00 | 800 | $175K | 20.7% |
| 3 | $225.00 | 1,500 | $338K | 39.9% |
| 4 | $226.00 | 1,000 | $226K | 26.7% |
| Total | $222.82 avg | 3,800 | $847K | 100% |
| Filing → |
| MDGL | SELL | 2025-01-27 | $35K | — | Filing → |
| MDGL | SELL | 2025-01-17 | $242K | — | Filing → |
| MDGL | SELL | 2024-06-18 | $532K | — | Filing → |